Kernel

🌍 Where in the world is our CEO, Ryan Field? This week he is in Bordeaux, France attending #Neuroergonomics2024 and meeting with some of the world’s experts on practical applications of fNIRS and EEG. Ryan will be presenting on the unique capabilities and real-world applications of Kernel's TD-NIRS systems, #Flow2 and #DevKit. 🧠

What if a headset could perform a brain scan? Scanning 80% of the brain at 2% of the cost, this is precisely what Kernel, a visionary startup, is doing. Discover how the American startup makes this challenge possible by utilizing ST’s Imaging Foundry services and how the Multi-Project Wafer (MPW) program has made a significant difference. Read the success story: http://spkl.io/60404A216 #OurTechnologyStartsWithYou #healthcare #healthcareaccess #precisionmedicine #medicine

What if a headset could perform a brain scan? Scanning 80% of the brain at 2% of the cost, this is precisely what Kernel, a visionary startup, is doing. Discover how the American startup makes this challenge possible by utilizing ST’s Imaging Foundry services and how the Multi-Project Wafer (MPW) program has made a significant difference. Read the success story: http://spkl.io/60404A216 #OurTechnologyStartsWithYou #healthcare #healthcareaccess #precisionmedicine #medicine

This week I'm excited to be a part of the first ever HLTH Europe conference in #Amsterdam. I will be participating in a panel on digital biomarkers with an exceptional group. With Shrawan Patel, MD Co-Founder of PharmStars moderating, it is sure to be a lively discussion between the panelists, including: - Alexandra Gonçalves, MD, MMSc, PhD - VP, Head of Digital Health at Bristol Myers Squibb - Katie Baca-Motes - Chief Strategy Officer at CareEvolution - Manuel Marina Breysse - Cardiologist and CEO at Idoven Each of us brings a unique perspective to the topic and I look forward to sharing some of how Kernel is working to make advances in #neuroscience accessible to everyone to improve care in #mentalhealth and diseases of #neurodegeneration (like #dementia). #HLTHEurope #HLTH #Medtech #DigitalHealth #HealthTech

After successful meetings in #AI, #biotech, #mentalhealth, #medtech, and #neurotech over the last few weeks, this week our CEO, Ryan Field, is at #ISOTT2024. He will be sharing the latest developments in our core technology that enables our work in #depression and #dementia. Our technology is what sets us apart!

Attending AI for Good in Geneva this week? Curious about Kernel Flow2? Come check it out for yourself! Ryan Field will be at booth 51 on Friday, May 31 from 9am-12pm & 1pm-2:30pm.

One of our newest #HealthTransformers and member of our #AlzMoonshot Community, Ryan Field, CEO of Kernel, is speaking at the AI for Good Summit this week on May 30. ⤵️ https://ow.ly/iqNl50RYr5n

🧠 Kernel and Focalpoint Partners will be at BIO in San Diego next week. We're hosting a space for founders, business development professionals, investors, and KOLs to come together and engage in discussion about the frontiers in neuromedicine across psychiatry and neurodegeneration. 📌 You can request to join here: https://lnkd.in/g3qh7U3H Ryan Field Brom Rector, CFA Rebecca Baken

I am excited to speak about our work and demo Kernel Flow2 at the AI for Good Summit in Geneva next week. I will be joining panelists Carolina Aguilar from INBRAIN Neuroelectronics, Andreas Forsland from Cognixion, and Sid Kouider of Snap Inc. (co-founder of NextMind) to discuss #Neurotech Horizons and the future we're all building around technologies for the #brain. This is a highly anticipated event hosted by the International Telecommunication Union and United Nations:  https://lnkd.in/gSyDTWm5 #ITUaiSummit

Excited to announce the first 14 companies to join StartUp Health's Alzheimer's Moonshot Community, launched earlier this year with support from Gates Ventures & Alzheimer's Drug Discovery Foundation. I just got off a virtual community kickoff session with our team and founders from all 14 companies (across 6 countries) and am feeling inspired, optimistic, and encouraged about how this group can make orogres, together, in the AD/ADRD space. 💜 A warm welcome 👋 to Marta Barrachina of ADmit Therapeutics, Venkat Shastri of ALZpath Inc., Christy K. Sheehy-Bensinger, PhD of C. Light Technologies, Inc., Luca Giani of Ilios Therapeutics, Ryan Field of Kernel, Nina Kiwit & Manuel Kraus of MindAhead, Paul Campbell & Jen Flexman, PhD, of Moneta Health, Nathan Intrator of Neurosteer, Eliav Shaked & Catherine Bornbaum, PhD, of RetiSpec, Ken Mariash of Sinaptica Therapeutics, Steven Visuri & Ryan Gordon of Stem Pharm, Fernando Johann of TELL Toolkit, Erwin L Roggen of ToxGenSolutions BV (TGS), and Allyson Schrier & William A. Uniowski of Zinnia. Phyllis Ferrell #AlzMoonshot #Alzheimers